Tau Levels Predict Memory Loss in Alzheimerβs
7 September 2024 at 16:32
Alzheimer's disease (AD) progression varies based on the presence of tau and amyloid-beta (AΞ²) proteins in the brain. Patients with high levels of both tau and AΞ² experience rapid memory decline, while those with high AΞ² but low tau show a slower progression. The research emphasizes that tau levels are crucial for diagnosing and managing AD effectively. This insight could lead to more personalized treatment strategies as biomarker technology advances.